NCT03348891View on ClinicalTrials.gov

TNF in Melanoma Patients Treated With Immunotherapy

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

March 3, 2021

Study Completion Date

November 22, 2021

Conditions
Melanoma
Interventions
OTHER

Tumor biopsy specimens and blood samples

Tumor biopsy specimens (if feasible) and blood samples will be collected at Baseline, Week 6 Day 1 (blood sample only) and Week 12 Day 1.

Trial Locations (3)

31059

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse

Unknown

CHRU Claude HURIEZ, Lille

CHU Montpellier Saint-Eloi, Montpellier

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT03348891 - TNF in Melanoma Patients Treated With Immunotherapy | Biotech Hunter | Biotech Hunter